US court invalidates key TEVA drug patent
Teva hopes Sanofi collaboration will lead to blockbuster IBD drug | Reuters
Teva rejects Israeli PM's request to keep Jerusalem plant open | Reuters
Teva reaches proposed $4.35 billion settlement of US opioid lawsuits | CNN Business
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
US judge overturns Eli Lilly's $176.5 million loss in Teva patent case | Reuters
Teva, Texas strike opioid settlement worth $225 million - The Jerusalem Post
Teva, armed with 2 recent launches, raises revenue guidance
PM to Teva boss: Minimize damage to workers, especially in periphery - Israel News - The Jerusalem Post
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
Teva to Acquire Mexico's Rimsa for $2.3 Billion - WSJ
Teva to pay up to $523 million to New York state to settle opioid suit | Business Insurance
Teva and Eli Lilly scrap over migraine drug rights — MedWatch
Teva Names Interim CEO, New Chairman As Vigodman Steps Down
Teva Pharmaceutical Is in Recovery - WSJ
Fears of Israeli job cuts at Teva sparks call for general strike | Reuters
Teva Pharm to stay as unified drugmaker, sees big interest in API business, says CEO | Reuters
/cloudfront-us-east-2.images.arcpublishing.com/reuters/PTTVJLJBQNLRBHDEX576PT7LII.jpg "Teva expects to start paying U.S. opioid settlement in 2023 | Reuters")
Teva expects to start paying U.S. opioid settlement in 2023 | Reuters
Teva Pharmaceuticals Slashing 25% of Workforce, Suspending Dividend
CVS Picks Migraine Drugs by Teva, Eli Lilly, Snubs Amgen, Reuters Reports | Ctech
Teva, AbbVie finalize $6.6 billion U.S. opioid settlements | Reuters
Drugmaker Teva does not see big impact on business from Israel-Hamas war | Reuters
